Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rhizen Pharma, Curon Biopharma sign exclusive licensing pact to develop and commercialise Tenalisib in Greater China

expresspharmaOctober 15, 2020

Tag: Rhizen , Curon , Tenalisib

PharmaSources Customer Service